IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $604,000 | +106.1% | 40,657 | +46.6% | 0.06% | +123.1% |
| Q4 2021 | $293,000 | -41.0% | 27,730 | -41.7% | 0.03% | +8.3% |
| Q3 2021 | $497,000 | -56.1% | 47,543 | -40.1% | 0.02% | -59.3% |
| Q2 2021 | $1,133,000 | +102.0% | 79,308 | +25.3% | 0.06% | +55.3% |
| Q1 2021 | $561,000 | +9.1% | 63,281 | +54.1% | 0.04% | -54.8% |
| Q3 2020 | $514,000 | -60.7% | 41,061 | -5.8% | 0.08% | -61.5% |
| Q2 2020 | $1,307,000 | +1.5% | 43,594 | -13.7% | 0.22% | -26.4% |
| Q1 2020 | $1,288,000 | – | 50,497 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |